Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 6,140 shares at $747.14 ($4.6M) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Seasonal sale ($4.6M) by Director — this insider has traded REGN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $747.14 | 3,070 | $2.3M | 50.0% |
| 2 | $747.14 | 3,070 | $2.3M | 50.0% |
| Total | $747.14 avg | 6,140 | $4.6M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |